Cover Image

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment

Saved in:

Bibliographic Details
Main Authors:	Taylor C. Duke, MD (Author), Ranjit Nair, MD (Author), Carlos Torres-Cabala, MD (Author), Rodabe N. Amaria, MD (Author), Elizabeth Keiser, MD (Author), Roberto Miranda, MD (Author), Swaminathan P. Iyer, MD (Author), Meghan Heberton, MD (Author)
Format:	Book
Published:	Elsevier, 2020-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
by: Zi-Yi Choo, BS, et al.
Published: (2023)

Relapsed angioimmunoblastic T-cell lymphoma presenting as psoriasiform dermatitis
by: Spencer McClure, MD, et al.
Published: (2023)

Epstein-Barr virus-positive, CD30-positive, diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma
by: Marc Grossman, MD, et al.
Published: (2022)

Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report
by: Jai Kumar Khatri MD, et al.
Published: (2024)

IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
by: Tristan V.M. Bruijn, MD, et al.
Published: (2024)

Hyponatremia and Fever in a Patient on Ipilimumab and Nivolumab (Immune Checkpoint Inhibitors): A Case Report
by: Sumit S. Patel MD, et al.
Published: (2021)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
by: Ander Mayor Ibarguren, MD, et al.
Published: (2021)

Gender Differences in the Incidence of Adverse Cardiovascular Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Sheharyar Minhas, MD, et al.
Published: (2020)

Checkpoint Inhibitor Induced Acute Liver Failure
by: Chukwunonso Ezeani MD, et al.
Published: (2024)

Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse
by: Christopher N. Nguyen, BA, et al.
Published: (2021)

Lichenoid tissue eruption of the vulva associated with immune checkpoint inhibitor
by: Maya I. Davis, BA, et al.
Published: (2024)

Review of Checkpoint Inhibitor Immunotherapy in Neuroendocrine Tumor of Prostate and Our Experience in 2 Cases
by: Akriti Pokhrel MD, et al.
Published: (2022)

Chemotherapy and Immune Checkpoint Inhibitors in a Case of SMARCA4-dUT: A Case Report and Review of Literature
by: Akriti Pokhrel MD, et al.
Published: (2023)

Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event
by: Jolanta Pach, BA, et al.
Published: (2021)

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
by: Song Y. Park, MD, et al.
Published: (2021)

Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy
by: Jasmine Rana, MD, et al.
Published: (2021)

Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma
by: Caitlin M. Brumfiel, MS, et al.
Published: (2021)

Pruritic papules in a longstanding tattoo
by: Chen Yao, MD, et al.
Published: (2022)

Severe recalcitrant cutaneous eruption with dual immune checkpoint blockade
by: Sakeena Fatima, BA, et al.
Published: (2018)

CUTANEOUS MANIFESTATIONS OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
by: N. G. Chernova, et al.
Published: (2018)

Cutaneous involvement in angioimmunoblastic T-cell lymphoma
by: Papadavid Evangelia, et al.
Published: (2010)

Angioimmunoblastic T-Cell Lymphoma: A Diagnostic Challenge
by: Jorge Ocampo-Garza, et al.
Published: (2014)

Association of lichen sclerosus and morphea with immune checkpoint therapy: a systematic review
by: Leah Shin, BA, et al.
Published: (2023)

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
by: Xi Chen, et al.
Published: (2022)

The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study
by: Jade N. Young, BS, et al.
Published: (2024)

Erythema Multiforme Major in Angioimmunoblastic T-cell Lymphoma
by: Shoko Hattori, et al.
Published: (2021)

Angioimmunoblastic T-cell Lymphoma: A Case Report
by: Sundus Nasim, et al.
Published: (2024)

Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression levelCapsule Summary
by: Barbara Meier-Schiesser, MD, PhD, et al.
Published: (2024)

An Unexpected Lymphoma: A Rare Case of Primary Gastric Burkitt's Lymphoma
by: Jonathan London MD, et al.
Published: (2024)

Plasmablastic Lymphoma Presenting as Extensive Peritoneal and Retroperitoneal Nodules in an HIV-Positive Patient
by: Akriti Pokhrel MD, et al.
Published: (2022)

Imatinib associated discoid lupus erythematosus in a patient with chronic myeloid leukemia
by: Priya Sarlashkar, BS, et al.
Published: (2024)

Oral ulcerations in a patient with mantle cell lymphoma
by: Miranda Rosenberg, MD, et al.
Published: (2020)

Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade
by: David M. Miller, MD, PhD, et al.
Published: (2017)

Immune checkpoint inhibitor induced lichenoid reactions: A systematic review of characteristics and treatment outcomes
by: Abrahim Abduelmula, BScN, et al.
Published: (2022)

Cutaneous balamuthiasis: A clinicopathological studyCapsule Summary
by: Patricia Alvarez, MD, et al.
Published: (2022)

Plasmablastic lymphoma masked by hidradenitis suppurativa
by: Sarah Preis, MD, et al.
Published: (2022)

Cutaneous follicle center lymphoma of the eyelids: Unusual location
by: Belcadi Jihane, MD, et al.
Published: (2022)

Aggressive Diffuse Intermediate Size B-Cell Lymphoma With P53 Mutation Presented as Primary Bone Marrow Lymphoma
by: Pei Ting Chen MD, et al.
Published: (2020)

Educational Case: Mantle Cell Lymphoma
by: Brenda Mai MD, et al.
Published: (2020)

Distinguishing reactive inflammatory dermatoses from lymphoma: 2 cases of severe drug reactions to phenytoin/phenobarbital and rosuvastatin mimicking lymphoma
by: Taylor Novice, BS, et al.
Published: (2020)